This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koga, T. Articles by Sueishi, K. Search for Related Content PubMed PubMed Citation Articles by Koga, T. Articles by Sueishi, K.

Clinicopathological and Molecular Evidence Indicating the Independence of Bronchioloalveolar Components from Other Subtypes of Human Peripheral Lung Adenocarcinoma

Pathophysiological and Experimental Pathology, Departments of Pathology [T. K., S. H., S. M., Y. M., K. Sue.], and General Surgery [K. Sugio, I. Y., K. Sugim.], Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

Although human lung adenocarcinoma has diverse histological subtypes, the correlation between histological subtypes and occurrence of the p53 gene mutation has been given less attention. We investigated 145 surgically resected lung adenocarcinomas to search for the incidence of p53 mutations and for record data on survival in each histological subtype, according to the new WHO criteria (1999). The frequency of p53 mutation in bronchioloalveolar carcinoma (BAC; 0% in 17 cases) and BAC with invasive growth component (BAC-invasive; 11% in 27 cases), which is conventionally categorized as the mixed subtype in WHO typing, were apparently significantly lower than in other types (non-BAC including acinar, papillary, solid, or mixed histology with these subtypes; 48% in 101 cases; P < 0.01). Multivariate analysis revealed that the histological subtype including BAC-invasive was a strong, independent, and significant prognostic factor (P < 0.03), as were tumor size and pathological stage (P < 0.001 and 0.002, respectively) for overall survival. However, the occurrence of p53 mutation itself was seen to be significant only in case of the univariate analysis. Therefore, histological subtyping may be a better prognostic indicator than is p53 mutation. These findings suggest that the WHO classification with the BAC and BAC-invasive from other histological subtypes may prove useful to predict the outcome for surgically treated patients with lung adenocarcinoma.

This article has been cited by other articles:

				D. J. Raz, B. He, R. Rosell, and D. M. Jablons Current concepts in bronchioloalveolar carcinoma biology. Clin. Cancer Res., June 15, 2006; 12(12): 3698 - 3704. [Full Text] [PDF]

				I. S. Sarkaria, D. Pham, R. A. Ghossein, S. G. Talbot, M. Hezel, M. E. Dudas, M. I. Ebright, S. Chuai, N. Memoli, E. S. Venkatraman, et al. SCCRO Expression Correlates With Invasive Progression in Bronchioloalveolar Carcinoma Ann. Thorac. Surg., November 1, 2004; 78(5): 1734 - 1741. [Abstract] [Full Text] [PDF]

				K. Takamochi, J. Yoshida, M. Nishimura, T. Yokose, S. Sasaki, Y. Nishiwaki, K. Suzuki, and K. Nagai Prognosis and histologic features of small pulmonary adenocarcinoma based on serum carcinoembryonic antigen level and computed tomographic findings Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 877 - 883. [Abstract] [Full Text] [PDF]

				M. A. L. Tan, S. Teichberg, B. Roberts, and S. I. Hajdu Ultrastructural Findings in Metastatic Bronchioloalveolar Carcinoma Ann. Clin. Lab. Sci., July 1, 2003; 33(3): 289 - 294. [Abstract] [Full Text] [PDF]

				N. Seki, T. Takasu, K. Mandai, M. Nakata, H. Saeki, Y. Heike, I. Takata, Y. Segawa, T. Hanafusa, and K. Eguchi Expression of Eukaryotic Initiation Factor 4E in Atypical Adenomatous Hyperplasia and Adenocarcinoma of the Human Peripheral Lung Clin. Cancer Res., October 1, 2002; 8(10): 3046 - 3053. [Abstract] [Full Text] [PDF]

				F. Darvishian, B. Roberts, S. Teichberg, and S. I. Hajdu Ultrastructural Comparison of "Alveolar" and "Solid" Areas in Bronchioloalveolar Carcinoma Ann. Clin. Lab. Sci., July 1, 2002; 32(3): 225 - 230. [Abstract] [Full Text] [PDF]